The FITC Anti-Human CD56 Antibody (5.1H11) available at AssayGenie is a cutting-edge tool for researchers investigating CD56, a marker found on natural killer cells and neural cell adhesion molecules. This antibody, specifically designed for human samples, allows for precise detection and analysis of CD56 expression in a variety of cell types.CD56, also known as neural cell adhesion molecule (NCAM), plays a pivotal role in cell-to-cell interactions, immune responses, and neural development. Research using this antibody can shed light on the function of CD56 in various biological processes, including immune surveillance, tissue regeneration, and neuroplasticity.
With its high reactivity and specificity, the FITC Anti-Human CD56 Antibody (5.1H11) is a valuable tool for immunologists, neuroscientists, and cancer biologists looking to explore the role of CD56 in health and disease. Whether studying immune cell function, neuronal communication, or tumor immunology, this antibody opens up new avenues for research and discovery.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P13591
Gene ID:
4684
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CD56 is a single transmembrane glycoprotein also known as NCAM (Neural Cell Adhesion Molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK cells and NK-T cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparin sulfate.